Here's why these 4 shares crashed on the market today

Are Nearmap Ltd (ASX:NEA), Stemcell United Ltd (ASX:SCU), Fletcher Building Limited (Australia) (ASX: FBU), and Slater & Gordon Limited (ASX:SGH) an opportunity?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Today was a flat day for the S&P/ASX 200 (INDEXASX: ^AXJO) (ASX: XJO), which fell 0.4% to 5,775 points. A number of shares fell significantly further however, and here's why:

Fletcher Building Limited (Australia) (ASX: FBU) dropped 10% to $7.53 after the company announced a downgrade to its full-year profit outlook. Fletcher now expects to earn between $610 million and $650 million for the full year, down from $720 million to $760 million previously. Fletcher shares are still up 11% compared to last year, however.

Nearmap Ltd (ASX: NEA)fell 3% to $0.53 on no news, as investors remain wary of the company's expansion into the USA. While Nearmap is not profitable, it is a minority player in both the Australian and US markets and is thought to have a strong pathway for growth ahead of it. Nearmap shares have risen 34% in the past 12 months.

Slater & Gordon Limited (ASX:SGH) lost 6% to $0.122 as enthusiasms cooled following a strong share price rise on Friday. With the business continuing to struggle and a possible debt to equity swap set to minimise the value of existing shareholder's stakes, the company is far too risky in my opinion and should be avoided. Slater & Gordon shares have fallen 55% over the past 12 months.

Stemcell United Ltd (ASX: SCU) plunged 12% to $0.185 on the tail of a ~1500% rise over the past few months. This tiny cap has been swept up in the excitement surrounding the marijuana sector at the moment, although as Foolish analyst Mike King warned, there are many possible reasons an investment in these companies could end in tears. Stemcell shares have skyrocketed since announcing their marijuana venture.

Motley Fool contributor Sean O'Neill owns shares of Nearmap Ltd. The Motley Fool Australia owns shares of Nearmap Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »